{
  "user_id": "USER123",
  "version": 1,
  "generated_at": "2025-09-19T20:10:00Z",
  "summary": "Weekly plan tailored to MTHFR (CT), CYP1A2 (AC), and LCT (TT) findings with focus on folate optimization and caffeine moderation.",
  "weeks": [
    {
      "week": 1,
      "recommendations": [
        {
          "type": "nutrition",
          "title": "Folate-rich meal targets",
          "details": "Include at least 2 servings/day of leafy greens (spinach, kale) and 1 serving of legumes.",
          "why": "CT genotype for MTHFR may reduce enzyme activity; dietary folate supports normal homocysteine.",
          "evidence_level": "B"
        },
        {
          "type": "habit",
          "title": "Caffeine cutoff",
          "details": "Limit caffeine intake to < 200 mg after 12:00.",
          "why": "Intermediate caffeine metabolism (CYP1A2 AC) may increase sensitivity late-day.",
          "evidence_level": "B"
        },
        {
          "type": "supplement",
          "title": "Methylfolate (check with clinician)",
          "details": "Consider 400â€“800 mcg/day after consultation.",
          "why": "CT genotype may benefit from methylated folate forms.",
          "evidence_level": "C"
        }
      ]
    }
  ],
  "changelog": [],
  "disclaimer": "Plans are guidance, not medical advice. Consult qualified professionals for diagnosis and treatment."
}
